Technical Analysis for INKT - MiNK Therapeutics, Inc.

Grade Last Price % Change Price Change
D 7.57 10.51% 0.72
INKT closed up 10.51 percent on Tuesday, December 7, 2021, on 1.42 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical INKT trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 10.51%
Lower Bollinger Band Walk Weakness 10.51%
New 52 Week Low Weakness 10.51%
Wide Bands Range Expansion 10.51%
Older End-of-Day Signals for INKT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 10 hours ago
Possible NR7 about 11 hours ago
Possible Inside Day about 11 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Up 5% about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate includes AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Pharmacy Stem Cells Cell Therapy Immune Mediated Diseases Lineage Cell Therapeutics Natural Killer T Cell T Cells

Is INKT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.16
52 Week Low 6.17
Average Volume 87,930
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 15.10
10-Day Moving Average 12.73
Average True Range 2.85
ADX 28.47
+DI 14.04
-DI 29.34
Chandelier Exit (Long, 3 ATRs) 12.86
Chandelier Exit (Short, 3 ATRs) 14.71
Upper Bollinger Bands 22.98
Lower Bollinger Band 7.22
Percent B (%b) 0.02
BandWidth 104.40
MACD Line -1.71
MACD Signal Line -0.49
MACD Histogram -1.2254
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.98
Resistance 3 (R3) 10.90 9.68 10.41
Resistance 2 (R2) 9.68 8.82 9.72 10.22
Resistance 1 (R1) 8.63 8.28 9.16 8.71 10.03
Pivot Point 7.41 7.41 7.68 7.45 7.41
Support 1 (S1) 6.36 6.55 6.89 6.44 5.11
Support 2 (S2) 5.14 6.01 5.18 4.92
Support 3 (S3) 4.09 5.14 4.73
Support 4 (S4) 4.17